BioNxt Solutions Inc.
BNXT
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 14.21% | -121.91% | -66.16% | -8.34% | -31.98% |
| Total Depreciation and Amortization | -89.80% | 119.51% | -80.37% | -76.33% | -70.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 67.02% | 207.86% | 147.14% | -16.63% | 6.74% |
| Change in Net Operating Assets | -240.10% | 156.28% | 149.00% | -205.49% | 304.63% |
| Cash from Operations | -8.38% | 53.85% | -1.45% | -770.59% | -2.51% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 946.15% | -12.59% | -- | -- | -96.84% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 946.15% | -12.59% | -- | -- | -96.84% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | 394.53% | 251.70% | 391.59% | -- | -54.34% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | 100.00% |
| Cash from Financing | 354.63% | -67.94% | -34.33% | -- | -52.67% |
| Foreign Exchange rate Adjustments | -- | -116.67% | 50.00% | -57.14% | -100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 456.94% | -115.04% | -769.79% | 300.42% | -241.53% |